[FinancialReports](/) / [Companies](/companies/search/) / [South Korea](/companies/countries/south-korea/) / **353810** ![EASY BIO, Inc. logo](https://cdn.financialreports.eu/financialreports/media/EASY%20BIO%2C%20Inc./other/EASY_BIO_Inc.-logo.easy_bio_inc_logo) # EASY BIO, Inc. — Investor Relations & Filings Ticker · **353810** ISIN · **KR7353810005** LEI · **988400OOAWY9V3ZW5E12** KO Manufacturing [Open in API](/api-solutions/) Overview Filings 174 Market data Peer group API Filings indexed 174 across all filing types Latest filing 2026-05-15 Interim / Quarterly Rep… Country KR South Korea Listing KO 353810 ## About EASY BIO, Inc. EASY BIO, Inc. is an animal nutrition company that develops, manufactures, and markets animal feed products and additives. The company specializes in solutions for the livestock industry, with a notable focus on piglet feed. It operates across the food value chain, managing feed mills and owning pork and poultry production facilities. Through its subsidiaries, EASY BIO also provides advanced services such as livestock diagnostics, integrating biotechnology into its core animal health and nutrition offerings. The company aims to establish a new standard in the animal industry by providing comprehensive solutions that support animal health and productivity. ## Recent filings View all 174 → | Filing | Released | Lang | Actions | | --- | --- | --- | --- | | [**분기보고서 (2026.03)**](/filings/easy-bio-inc/interim-quarterly-report/2026/46362841/) Interim / Quarterly Report Classification · 97% confidence The document is titled “분기보고서” (Quarterly Report) for the 7th fiscal year, covering the period January 1, 2026 to March 31, 2026. It contains detailed business descriptions, segment financials, actual financial data tables (revenues, assets, liabilities, production capacity, segment info, etc.). This matches the definition of an Interim/Quarterly Report under category IR, as it is a comprehensive financial report for a period shorter than a full fiscal year with substantive financial statements and analysis. · Q1 2026 | 2026-05-15 | Korean | | | [**기업가치제고계획(자율공시)**](/filings/easy-bio-inc/regulatory-filings/2026/33135204/) Regulatory Filings Classification · 66% confidence The document is a voluntary regulatory disclosure (“자율공시”) presenting the company’s corporate value enhancement plan. It is not an Annual Report, financial statement, earnings release, dividend notice, or other specific category (e.g., M&A, board changes). It does not announce the publication of another report but itself contains the plan details. Therefore it falls under the fallback “Regulatory Filings” category (RNS). | 2026-04-01 | Korean | | | [**정기주주총회결과**](/filings/easy-bio-inc/declaration-of-voting-results-voting-rights-announcements/2026/33115884/) Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the official results of the annual general shareholders’ meeting (‘정기주주총회결과’) held on 2026-03-31. It details each agenda item, voting results (approval rates, vote counts), approval of financial statements, dividend resolutions, director elections, and related vote percentages. This corresponds exactly to shareholders’ vote result disclosures, fitting the Declaration of Voting Results & Voting Rights Announcements category. | 2026-03-31 | Korean | | | [**대표이사변경**](/filings/easy-bio-inc/boardmanagement-information/2026/33115866/) Board/Management Information Classification · 95% confidence The document text is a corporate announcement detailing the resignation and appointment of representative directors (CEO changes), including dates of board resolution and profiles of new appointees. This clearly fits the definition of a Board/Management Information filing, as it announces changes in senior management. | 2026-03-31 | Korean | | | [**사외이사의선임ㆍ해임또는중도퇴임에관한신고**](/filings/easy-bio-inc/boardmanagement-information/2026/33115862/) Board/Management Information Classification · 93% confidence The document is a statutory filing to the Financial Services Commission/Korea Exchange reporting the appointment, reappointment, dismissal, or resignation of outside directors. It details changes in board composition and director terms. This clearly falls under Board/Management Information. | 2026-03-31 | Korean | | | [**사업보고서 (2025.12)**](/filings/easy-bio-inc/audit-report-information/2026/33014688/) Audit Report / Information Classification · 93% confidence The document is a standalone independent auditor’s report (감사보고서) with the auditor’s opinion, a complete set of audited financial statements (balance sheet, income statement, cash flow, notes), and audit procedures. It does not include broader management discussion, share listing details beyond the audit, or AGM materials, so it fits the definition of an Audit Report / Information (AR). · FY 2025 | 2026-03-23 | Korean | | ## Browse filings by year 7 years - [2026 14 filings](/companies/easy-bio-inc/2026/) - [2025 17 filings](/companies/easy-bio-inc/2025/) - [2024 32 filings](/companies/easy-bio-inc/2024/) - [2023 26 filings](/companies/easy-bio-inc/2023/) - [2022 25 filings](/companies/easy-bio-inc/2022/) - [2021 31 filings](/companies/easy-bio-inc/2021/) - [2020 29 filings](/companies/easy-bio-inc/2020/) [["13", "AGM Information"], ["1", "Annual Report"], ["53", "Audit Report / Information"], ["47", "Board/Management Information"], ["48", "Capital/Financing Update"], ["22", "Declaration of Voting Results & Voting Rights Announcements"], ["50", "Delisting Announcement"], ["20", "Director's Dealing"], ["6", "Earnings Release"], ["19", "Interim / Quarterly Report"], ["23", "M&A Activity"], ["24", "Major Shareholding Notification"], ["45", "Notice of Dividend Amount"], ["46", "Proxy Solicitation & Information Statement"], ["18", "Regulatory Filings"], ["51", "Share Issue/Capital Change"], ["52", "Transaction in Own Shares"]] [["100", "Korean"]] Financial Reporting & Info Annual General Meeting Debt Information Equity Information Listing/Delisting M&A, Partnerships & Legal Management & Remuneration Other Filing type Language Start date End date Apply filters [Clear](/companies/easy-bio-inc/) Report missing filing Download originals Download Markdown | | ID | Filing | Released | Lang | Actions | | --- | --- | --- | --- | --- | --- | | [2026](/companies/easy-bio-inc/2026/) 14 filings | | | | | | | | 46362841 | [**분기보고서 (2026.03)**](/filings/easy-bio-inc/interim-quarterly-report/2026/46362841/) Interim / Quarterly Report Classification · 97% confidence The document is titled “분기보고서” (Quarterly Report) for the 7th fiscal year, covering the period January 1, 2026 to March 31, 2026. It contains detailed business descriptions, segment financials, actual financial data tables (revenues, assets, liabilities, production capacity, segment info, etc.). This matches the definition of an Interim/Quarterly Report under category IR, as it is a comprehensive financial report for a period shorter than a full fiscal year with substantive financial statements and analysis. · Q1 2026 | 2026-05-15 | Korean | | | | 33135204 | [**기업가치제고계획(자율공시)**](/filings/easy-bio-inc/regulatory-filings/2026/33135204/) Regulatory Filings Classification · 66% confidence The document is a voluntary regulatory disclosure (“자율공시”) presenting the company’s corporate value enhancement plan. It is not an Annual Report, financial statement, earnings release, dividend notice, or other specific category (e.g., M&A, board changes). It does not announce the publication of another report but itself contains the plan details. Therefore it falls under the fallback “Regulatory Filings” category (RNS). | 2026-04-01 | Korean | | | | 33115884 | [**정기주주총회결과**](/filings/easy-bio-inc/declaration-of-voting-results-voting-rights-announcements/2026/33115884/) Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the official results of the annual general shareholders’ meeting (‘정기주주총회결과’) held on 2026-03-31. It details each agenda item, voting results (approval rates, vote counts), approval of financial statements, dividend resolutions, director elections, and related vote percentages. This corresponds exactly to shareholders’ vote result disclosures, fitting the Declaration of Voting Results & Voting Rights Announcements category. | 2026-03-31 | Korean | | | | 33115866 | [**대표이사변경**](/filings/easy-bio-inc/boardmanagement-information/2026/33115866/) Board/Management Information Classification · 95% confidence The document text is a corporate announcement detailing the resignation and appointment of representative directors (CEO changes), including dates of board resolution and profiles of new appointees. This clearly fits the definition of a Board/Management Information filing, as it announces changes in senior management. | 2026-03-31 | Korean | | | | 33115862 | [**사외이사의선임ㆍ해임또는중도퇴임에관한신고**](/filings/easy-bio-inc/boardmanagement-information/2026/33115862/) Board/Management Information Classification · 93% confidence The document is a statutory filing to the Financial Services Commission/Korea Exchange reporting the appointment, reappointment, dismissal, or resignation of outside directors. It details changes in board composition and director terms. This clearly falls under Board/Management Information. | 2026-03-31 | Korean | | | | 33014688 | [**사업보고서 (2025.12)**](/filings/easy-bio-inc/audit-report-information/2026/33014688/) Audit Report / Information Classification · 93% confidence The document is a standalone independent auditor’s report (감사보고서) with the auditor’s opinion, a complete set of audited financial statements (balance sheet, income statement, cash flow, notes), and audit procedures. It does not include broader management discussion, share listing details beyond the audit, or AGM materials, so it fits the definition of an Audit Report / Information (AR). · FY 2025 | 2026-03-23 | Korean | | | | 32983188 | [**감사보고서제출**](/filings/easy-bio-inc/audit-report-information/2026/32983188/) Audit Report / Information Classification · 99% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed with the KRX. It provides a summary of the audit opinion (which is '적정' or 'unqualified') and key financial data (assets, liabilities, revenue, profit) for the current and previous fiscal years. According to the 'Menu vs Meal' rule, this is an announcement of the audit report's submission rather than the full, multi-page audit report document itself. In the context of Korean regulatory filings (DART/KIND), this specific type of disclosure is categorized as a Report Publication Announcement (RPA). · FY 2025 | 2026-03-19 | Korean | | | | 32959946 | [**주주총회소집공고**](/filings/easy-bio-inc/proxy-solicitation-information-statement/2026/32959946/) Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Easy Bio Co., Ltd. It contains the meeting agenda, date, location, and detailed management information including board activities, remuneration, and related party transactions. This document is a formal proxy statement and notice sent to shareholders to inform them of the upcoming Annual General Meeting (AGM) and to solicit their votes on various agenda items. In the context of the provided categories, this fits the definition of a Proxy Solicitation & Information Statement. | 2026-03-17 | Korean | | | | 32959945 | [**의결권대리행사권유참고서류**](/filings/easy-bio-inc/proxy-solicitation-information-statement/2026/32959945/) Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy/Voting Rights) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the meeting date, agenda items (approval of financial statements, election of directors, etc.), and instructions for electronic voting. This is a standard proxy solicitation document used to request shareholder votes for a general meeting. | 2026-03-17 | Korean | | | | 32956193 | [**매출액또는손익구조30%(대규모법인은15%)이상변동**](/filings/easy-bio-inc/earnings-release/2026/32956193/) Earnings Release Classification · 95% confidence The document is a regulatory filing from a Korean company (E-Z Bio) announcing a significant change in financial results (revenue or profit structure change of 30% or more). This is a standard disclosure requirement for publicly traded companies in Korea (often filed via DART). Since it provides key financial highlights and performance metrics for the fiscal year, but is not a full annual report or a conference call transcript, it falls under the category of an Earnings Release (ER) as it serves as the initial announcement of financial performance. · FY 2025 | 2026-03-16 | Korean | | | | 32956173 | [**주주총회소집결의**](/filings/easy-bio-inc/proxy-solicitation-information-statement/2026/32956173/) Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company '이지바이오'. It outlines the date, location, agenda items (such as approval of financial statements, appointment of directors, and remuneration limits), and details regarding the nominees. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting agendas and to request their participation/votes. | 2026-03-16 | Korean | | | | 32907486 | [**배당락**](/filings/easy-bio-inc/notice-of-dividend-amount/2026/32907486/) Notice of Dividend Amount Classification · 100% confidence The document is a short announcement regarding '배당락' (ex-dividend date) for the company '이지바이오'. It provides specific details such as the company name, stock type, reference price, and the effective date of the ex-dividend. This is a standard corporate announcement regarding dividend-related events, which falls under the category of dividend notifications. | 2026-03-06 | Korean | | | | 32542836 | [**현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정**](/filings/easy-bio-inc/notice-of-dividend-amount/2026/32542836/) Notice of Dividend Amount Classification · 98% confidence The document is a regulatory announcement from E-Z Bio regarding the determination of a record date for cash/in-kind dividends. It specifies the record date (2026-03-10) and the purpose (confirming shareholders for profit distribution). Since this is an announcement regarding dividend-related procedures rather than the actual payment declaration or a financial report, it falls under the category of general regulatory announcements. | 2026-02-20 | Korean | | | | 32542681 | [**현금ㆍ현물배당결정**](/filings/easy-bio-inc/notice-of-dividend-amount/2026/32542681/) Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Eezy Bio regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend yield, the total dividend amount, and the record date. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders. | 2026-02-20 | Korean | | | [2025](/companies/easy-bio-inc/2025/) 1 filing | | | | | | | | 10217759 | [**금전대여결정**](/filings/easy-bio-inc/capitalfinancing-update/2025/10217759/) Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (E-Z Bio) detailing a board decision to provide a loan (capital financing) to a subsidiary (Pathway Intermediates USA, LLC). It outlines the loan amount, interest rate, purpose, and board approval details. Since this is a specific corporate announcement regarding financing activities that does not fit into the other specialized categories like M&A or share issuance, it is classified as a general regulatory filing. | 2025-12-17 | Korean | | Page **1** of **12** 1 [2](?page=2) [3](?page=3) … [Next](?page=2) ## Market data ### Market data not available Last price Market cap volume Day range today 52-week range trailing ### Price history 1Y 5Y 10Y ## Peer group · Manufacture of prepared animal feeds 56 peers | Company | Ticker | Country | Sector | | --- | --- | --- | --- | | [**Ajooni Biotech Limited**](/companies/ajooni-biotech-limited/) Produces animal healthcare solutions and nutritional supple… | AJOONI | IN | Manufacturing | | [**Algae Biosciences Corporation**](/companies/algae-biosciences-corporation/) Develops algae-based feed supplements for cattle, reducing … | ABV | CA | Manufacturing | | [**ALIBA SA**](/companies/aliba-sa/) Specializes in animal nutrition, developing balanced feed f… | — | AR | Manufacturing | | [**ANPARIO PLC**](/companies/anpario-plc/) Manufactures natural feed additives for animal health, nutr… | ANP | GB | Manufacturing | | [**Avanti Feeds ltd.**](/companies/avanti-feeds-ltd/) Produces shrimp feed and processes shrimp for export throug… | AVANTIFEED | IN | Manufacturing | | [**CARR'S GROUP PLC**](/companies/carrs-group-plc/) An international specialist in nutritional supplements for … | CARR | GB | Manufacturing | | [**CHUBU SHIRYO CO.,LTD.**](/companies/chubu-shiryo-coltd/) Manufactures feed for livestock and aquaculture, and organi… | 2053 | JP | Manufacturing | | [**Công ty Cổ phần Đầu tư Du lịch và Phát triển Thủy sản**](/companies/cong-ty-co-phan-au-tu-du-lich-va-phat-trien-thuy-san/) Produces and supplies fish meal and fish oil from Pangasius… | DAT | VN | Manufacturing | | [**Darford International Inc.**](/companies/darford-international-inc/) Manufacturer of premium, all-natural, oven-baked dog food a… | WUF | CA | Manufacturing | | [**Easy Holdings Co., Ltd.**](/companies/easy-holdings-co-ltd/) An integrated holding company operating across the food val… | 035810 | KR | Manufacturing | Page **1** of **6** 1 [2](?peer_page=2) [3](?peer_page=3) … [Next](?peer_page=2) ### EASY BIO, Inc. via the API Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec. [Get API access](/api-solutions/) [Read API reference](/developers/reference/) Base URLapi.financialreports.eu Auth headerx-api-key Company ID17047 Ticker353810 ISINKR7353810005 ### Endpoints most-used routes for this company | | | | | --- | --- | --- | | GET | /api/companies/17047/ | Company identity, sector, listing, identifiers | | GET | /api/filings/?company=17047 | Paginated list of all filings (filterable by type, date, language) | | GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status | | GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) | | GET | /api/isins/?company=17047 | All ISINs registered to this company | | GET | /api/filing-types/ | Reference: every filing-type code + category | Full reference: [API reference](/developers/reference/) · [OpenAPI schema](/api/schema/) ### cURL latest filings for EASY BIO, Inc. ``` $ curl https://api.financialreports.eu/api/filings/?company=17047 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json" ``` ### Python requests ``` import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17047}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"] ``` ### MCP server Claude · Claude Code · ChatGPT [Claude setup →](/integrations/claude/) [ChatGPT setup →](/integrations/chatgpt/) [Claude Code setup →](/integrations/claude-code/) ``` // MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for EASY BIO, Inc. (id: 17047)" ``` #### AI · Markdown Filings as Markdown Drop the latest filing into Claude or ChatGPT, or query via MCP from your client. [Open Markdown↗](/filings/easy-bio-inc/interim-quarterly-report/2026/46362841/) [Open in MCP↗](/integrations/claude/) [cURL endpoint$](/api-solutions/) #### Identity Legal nameEASY BIO, Inc. HQSeoul, KR ListingKO ISINKR7353810005 LEI988400OOAWY9V3ZW5E12 Sector[Manufacturing](/companies/sectors/manufacturing/) Industry[Manufacture of prepared animal feeds](/companies/sectors/manufacturing/manufacture-of-prepared-animal-feeds/) #### Coverage Filings indexed 174 Next annual report Mar 18–Mar 24, 2027 Confidence 100% ### Report missing filing Can't find a specific document? Let us know and we'll add it within 24 hours. What is missing or wrong? Your email We will notify you once the filing is added. Cancel Send report Sending… Report sent Thank you. We will check the data and update it shortly. × (function() { const tabs = document.querySelectorAll('.cmp-tabs-wrap .fr-tab'); const panes = document.querySelectorAll('.tab-pane'); function activate(target, pushHash) { tabs.forEach(t => { const isActive = t.dataset.tab === target; t.classList.toggle('fr-tab--active', isActive); t.setAttribute('aria-selected', isActive ? 'true' : 'false'); }); panes.forEach(p => { const isActive = p.dataset.pane === target; p.classList.toggle('tab-pane--active', isActive); p.hidden = !isActive; }); if (pushHash) { try { history.replaceState(null, '', '#' + target); } catch (e) {} } } tabs.forEach(tab => { tab.addEventListener('click', () => { activate(tab.dataset.tab, true); window.scrollTo({ top: 0, behavior: 'instant' }); }); }); const initial = (window.location.hash || '').replace('#', ''); const validTabs = ['overview', 'filings', 'financials', 'market', 'peers', 'api']; const legacyMap = { 'market-data': 'market', 'peer-group': 'peers' }; let target = legacyMap[initial] || (validTabs.indexOf(initial) >= 0 ? initial : 'overview'); if (target !== 'overview') activate(target, false); })();